SE391180B - Sett att framstella 2,4-diamino-5-(3',4',5'-trietoxibensyl)-pyrimidiner - Google Patents

Sett att framstella 2,4-diamino-5-(3',4',5'-trietoxibensyl)-pyrimidiner

Info

Publication number
SE391180B
SE391180B SE7204847A SE484772A SE391180B SE 391180 B SE391180 B SE 391180B SE 7204847 A SE7204847 A SE 7204847A SE 484772 A SE484772 A SE 484772A SE 391180 B SE391180 B SE 391180B
Authority
SE
Sweden
Prior art keywords
triethoxybenzyl
pyrimidines
diamino
preparing
Prior art date
Application number
SE7204847A
Other languages
English (en)
Inventor
B Roth
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE391180B publication Critical patent/SE391180B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7204847A 1971-04-16 1972-04-14 Sett att framstella 2,4-diamino-5-(3',4',5'-trietoxibensyl)-pyrimidiner SE391180B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (1)

Publication Number Publication Date
SE391180B true SE391180B (sv) 1977-02-07

Family

ID=9875880

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7204847A SE391180B (sv) 1971-04-16 1972-04-14 Sett att framstella 2,4-diamino-5-(3',4',5'-trietoxibensyl)-pyrimidiner

Country Status (13)

Country Link
JP (3) JPS5320511B1 (sv)
AU (1) AU468447B2 (sv)
BE (1) BE782153A (sv)
CA (1) CA967964A (sv)
CH (1) CH565160A5 (sv)
CS (1) CS181221B2 (sv)
DE (1) DE2218220A1 (sv)
DK (1) DK131466B (sv)
FR (1) FR2133752B1 (sv)
GB (1) GB1407971A (sv)
IL (3) IL39218A (sv)
NL (1) NL7205043A (sv)
SE (1) SE391180B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
GB1261455A (en) * 1969-03-06 1972-01-26 Burroughs Wellcome Co Improvements in or relating to substituted acrylonitriles

Also Published As

Publication number Publication date
BE782153A (fr) 1972-10-16
JPS5422994B2 (sv) 1979-08-10
CH565160A5 (sv) 1975-08-15
AU468447B2 (en) 1976-01-15
JPS5430189A (en) 1979-03-06
NL7205043A (sv) 1972-10-18
CA967964A (en) 1975-05-20
IL39218A0 (en) 1972-06-28
DK131466B (da) 1975-07-21
DE2218220A1 (de) 1972-11-02
IL47921A0 (en) 1975-11-25
AU4117472A (en) 1973-10-18
JPS5320511B1 (sv) 1978-06-27
DK131466C (sv) 1975-12-08
IL47921A (en) 1976-10-31
CS181221B2 (en) 1978-03-31
JPS53111083A (en) 1978-09-28
IL39218A (en) 1976-10-31
FR2133752B1 (sv) 1975-04-25
GB1407971A (en) 1975-10-01
FR2133752A1 (sv) 1972-12-01

Similar Documents

Publication Publication Date Title
AR197970A1 (es) Derivados de 1,3,5-triazina
SE373583B (sv) Sett att framstella 4' -n- tertieramino-metyl-2', 11-spirodibenso Ÿb,eŸ oxepin-1',3'- dioxolaner
SE403478B (sv) Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
SE392103B (sv) Sett att framstella 1,2-bensisotiazolin-3-oner
SE406327B (sv) Sett att framstella d-homo-1,4-pregnadien-3,20-dioner
SE385707B (sv) Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat
SE393110B (sv) Sett att framstella nya 5-(3-jodpropargyloxi) pyrimidiner
SE399560B (sv) Sett att framstella salter av oŸ2,2'-anhydro-1-(3'-o-acyl-5'-o-acylbeta-d-arabinofuranosyl)-cytosiner
BG17798A3 (bg) Метод за получаване на нови 2-аминоалкил-аминотиено (3,2-d)пиримидини
SE398234B (sv) Sett att framstella kondenserade pyrimidinderivat
SE391180B (sv) Sett att framstella 2,4-diamino-5-(3',4',5'-trietoxibensyl)-pyrimidiner
FI55845C (fi) Foerfarande foer framstaellning av en 8-d-ribityl-pyrido(2,3-d)pyrimidin
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SU446967A3 (ru) Способ получения -замещенных2-(5-нитро-2-фурил)-4-аминотиено (2,3- )пиримидинов
SE405118B (sv) Sett att framstella 2,4-diamino-5-bensylpyrimidiner
SE385903B (sv) Sett att framstella 3,16alfa,17xi-trihydroxi-11beta-alkoxi-ostra-1,3,5 (10)- triener
SE403107B (sv) Sett att framstella 6-substituerade 3-etoxi-karbonyl hydrazino-pyridaziner
SE405729B (sv) Sett att framstella 3,4-dihydro-2-(1h)-kinazolinderivat
SE385012B (sv) Sett att framstella 4,9,11 - trien-steroid-derivat
SE396751B (sv) Sett att framstella s?72iv-benso-1,2,4-tiadiaziner
SE385302B (sv) Sett att framstella 5-aminometyl-6-karbetoxi-oxazino(5',6'e)indolderivat
AR192245A1 (es) Procedimiento para la preparacion de pirimidinas 2,5-disubstituidas
IL36040A (en) Manufacture of 1,1'-disubstituted-4,4'bipyridylium salts
SE384209B (sv) Sett att framstella 1,1'-disubstituerade-4,4'-bipyridyliumsalter
SE384854B (sv) Sett att framstella 1-bensoyloxi-2-lagalylaminobensocykloalkanderivat